TRUMY News and Press, Terumo Corp. ADR From 07/14/21

Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System - Represents the next generation technology for peripheral vascular embolization - PR Newswire SOMERSET, N.J. , July 14, 2021 /PRNewswire/ -- Teru...

The leading player in the market for blood plasma collection equipment. The plasma market is a duopoly with Fresenius in a distant number two position. Recent price weakness represents a significant opportunity to own a good quality leader at a very good price. The market has over...

Terumo Corporation (TRUMF) Q4 2021 Results Conference Call May 13, 2021 10:00 AM ET Company Participants Shinjiro Sato - President and CEO Naoki Muto - CFO Conference Call Participants Presentation Naoki Muto I am the CFO, Muto. I will now explain the results for the fiscal year ended March 2...

Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO Contributions will Help Bolster Vaccine Equity PR Newswire TOKYO , May 13, 2021 /PRNewswire/ -- As the world joins together to fight the ongoing battle against th...

The following slide deck was published by Terumo Corporation in conjunction with their 2021 Q4 earnings call. For further details see: Terumo Corporation 2021 Q4 - Results - Earnings Call Presentation

Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform Plasma is key ingredient for therapies crucial to treating patients affected by life-threatening conditions PR Newswire LAKEWOOD, Colo. and BO...

Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients PR Newswire LEUVEN, Belgium , April 12, 2021 /PRNewswire/ -- Terumo is proud to announce the launch of its Global Therapeutic Interventional...

Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. - Transaction furthers Terumo's efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of c...

A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan Aiming to Reduce the Burden on Patients Receiving Ambulatory Chemotherapy PR Newswire TOKYO , Feb. 7, 2021 /PRNewswire/ -- Terumo Corporation (...

Terumo Corporation (TRUMF) Q3 2021 Earnings Conference Call February 05, 2021 9:00 AM ET Company Participants Naoki Muto - CAFO Conference Call Participants Presentation [Interpreted] I am the CAFO, Muto. I will now explain the third quarter results for the fiscal year ending March 2021. Firs...